BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38928130)

  • 41. Sortilin-derived peptides promote pancreatic beta-cell survival through CREB signaling pathway.
    Daziano G; Blondeau N; Béraud-Dufour S; Abderrahmani A; Rovère C; Heurteaux C; Mazella J; Lebrun P; Coppola T
    Pharmacol Res; 2021 May; 167():105539. PubMed ID: 33737242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.
    Elksnis A; Schiffer TA; Palm F; Wang Y; Cen J; Turpaev K; Ngamjariyawat A; Younis S; Huang S; Shen Y; Leng Y; Bergsten P; Karlsborn T; Welsh N; Wang X
    Clin Sci (Lond); 2021 Oct; 135(19):2243-2263. PubMed ID: 34569605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pancreatic β-cell identity in diabetes.
    Remedi MS; Emfinger C
    Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):110-6. PubMed ID: 27615139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.
    Seino S; Sugawara K; Yokoi N; Takahashi H
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():22-29. PubMed ID: 28880474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
    Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
    Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1.
    Zhang S; Huang F; Tian W; Lai J; Qian L; Hong W; Chen H; Li LC
    Biochem Pharmacol; 2020 Apr; 174():113785. PubMed ID: 31887289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
    Cheng ST; Chen L; Li SY; Mayoux E; Leung PS
    PLoS One; 2016; 11(1):e0147391. PubMed ID: 26807719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat.
    Khan S; Jena G
    J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():195-227. PubMed ID: 33539017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
    Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
    Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tungstate promotes β-cell survival in Irs2-/- mice.
    Oliveira JM; Rebuffat SA; Gasa R; Burks DJ; Garcia A; Kalko SG; Zafra D; Guinovart JJ; Gomis R
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E36-47. PubMed ID: 24253047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The undoing and redoing of the diabetic β-cell.
    Wang W; Liu C; Jimenez-Gonzalez M; Song WJ; Hussain MA
    J Diabetes Complications; 2017 May; 31(5):912-917. PubMed ID: 28242267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes.
    Page KA; Reisman T
    Curr Diab Rep; 2013 Apr; 13(2):252-60. PubMed ID: 23371283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compensatory mechanisms of pancreatic beta cells: insights into the therapeutic perspectives for diabetes.
    Regazzi R; Dalle S; Abderrahmani A
    J Diabetes Res; 2014; 2014():217387. PubMed ID: 25133190
    [No Abstract]   [Full Text] [Related]  

  • 56. The future of diabetes treatment.
    Petersen JS
    Ann Endocrinol (Paris); 2008 Apr; 69(2):166-7. PubMed ID: 18440491
    [No Abstract]   [Full Text] [Related]  

  • 57. Diabetes area patent participation analysis - part II: years 2011-2016.
    Boehm M; Crawford M; Moscovitz JE; Carpino PA
    Expert Opin Ther Pat; 2018 Feb; 28(2):111-122. PubMed ID: 29140125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
    Mihailidou C; Chatzistamou I; Papavassiliou AG; Kiaris H
    Pflugers Arch; 2016 Nov; 468(11-12):1957-1968. PubMed ID: 27757583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreatic β-cells and restoring their dysfunction.
    Semwal DK; Kumar A; Aswal S; Chauhan A; Semwal RB
    Phytother Res; 2021 Mar; 35(3):1218-1229. PubMed ID: 32987447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenylpropenoic acid glucoside augments pancreatic beta cell mass in high-fat diet-fed mice and protects beta cells from ER stress-induced apoptosis.
    Mathijs I; Da Cunha DA; Himpe E; Ladriere L; Chellan N; Roux CR; Joubert E; Muller C; Cnop M; Louw J; Bouwens L
    Mol Nutr Food Res; 2014 Oct; 58(10):1980-90. PubMed ID: 25044754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.